View in EDS

Comparison of the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus.

Saved in:
Bibliographic Details
Title: Comparison of the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus.
Authors: Cruz-Ferretti, U.1 drferretti@hotmail.com, Llanes-Garza, H. A.1, López-Cabrera, N. G.1, Espinosa-Galindo, A. M.1, Palacios-Ríos, D.1, Cano-García, M. A.1, Estrada-Solís, Y. N.1
Source: Medicina Universitaria. jul-sep2014, Vol. 16 Issue 64, p107-111. 5p.
Subjects: ONDANSETRON, NALBUPHINE, ITCHING, MORPHINE, ANALGESIA, PHYSIOLOGY, THERAPEUTICS
Abstract: Objective: To compare the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus, in patients at the "Dr. José Eleuterio González" University Hospital from September 2012 to August 2013. Material and methods: A controlled, prospective, randomized study of 28 patients (14 per group) receiving neuraxial morphine analgesia was conducted, which was registered and approved by the Ethics Committee of the Institution and patients agreed to participate in the study under informed consent. The results were segmented and contrasted (according to drug) by hypothesis testing; the association was determined by X² with a 95% confidence interval (CI). Results: Pruritus was effectively resolved in both groups and no significant difference was found in the rest of the variables. An increase in the visual analogue scale (EVA) was observed at 6 and 12 hours for the ondansetron group, which was statistically significant (p≤0.05), however both groups had an EVA of less than 3. Conclusions: When comparing the efficacy and safety of ondansetron 4 mg vs. nalbuphine 4 mg for the treatment of neuraxial morphine induced pruritus, the only significant difference found was the mean EVA at 6 and 12 hours, favoring the ondansetron group. However, both groups scored less than 3 on the EVA. Therefore, we consider that both treatments are effective and safe in the treatment of pruritus caused by neuraxial morphine. [ABSTRACT FROM AUTHOR]
Copyright of Medicina Universitaria is the property of Medicina Universitaria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 109202194
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparison of the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cruz-Ferretti%2C+U%2E%22">Cruz-Ferretti, U.</searchLink><relatesTo>1</relatesTo><i> drferretti@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Llanes-Garza%2C+H%2E+A%2E%22">Llanes-Garza, H. A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22López-Cabrera%2C+N%2E+G%2E%22">López-Cabrera, N. G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Espinosa-Galindo%2C+A%2E+M%2E%22">Espinosa-Galindo, A. M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Palacios-Ríos%2C+D%2E%22">Palacios-Ríos, D.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Cano-García%2C+M%2E+A%2E%22">Cano-García, M. A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Estrada-Solís%2C+Y%2E+N%2E%22">Estrada-Solís, Y. N.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Medicina+Universitaria%22">Medicina Universitaria</searchLink>. jul-sep2014, Vol. 16 Issue 64, p107-111. 5p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22ONDANSETRON%22">ONDANSETRON</searchLink><br /><searchLink fieldCode="DE" term="%22NALBUPHINE%22">NALBUPHINE</searchLink><br /><searchLink fieldCode="DE" term="%22ITCHING%22">ITCHING</searchLink><br /><searchLink fieldCode="DE" term="%22MORPHINE%22">MORPHINE</searchLink><br /><searchLink fieldCode="DE" term="%22ANALGESIA%22">ANALGESIA</searchLink><br /><searchLink fieldCode="DE" term="%22PHYSIOLOGY%22">PHYSIOLOGY</searchLink><br /><searchLink fieldCode="DE" term="%22THERAPEUTICS%22">THERAPEUTICS</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: To compare the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus, in patients at the "Dr. José Eleuterio González" University Hospital from September 2012 to August 2013. Material and methods: A controlled, prospective, randomized study of 28 patients (14 per group) receiving neuraxial morphine analgesia was conducted, which was registered and approved by the Ethics Committee of the Institution and patients agreed to participate in the study under informed consent. The results were segmented and contrasted (according to drug) by hypothesis testing; the association was determined by X² with a 95% confidence interval (CI). Results: Pruritus was effectively resolved in both groups and no significant difference was found in the rest of the variables. An increase in the visual analogue scale (EVA) was observed at 6 and 12 hours for the ondansetron group, which was statistically significant (p≤0.05), however both groups had an EVA of less than 3. Conclusions: When comparing the efficacy and safety of ondansetron 4 mg vs. nalbuphine 4 mg for the treatment of neuraxial morphine induced pruritus, the only significant difference found was the mean EVA at 6 and 12 hours, favoring the ondansetron group. However, both groups scored less than 3 on the EVA. Therefore, we consider that both treatments are effective and safe in the treatment of pruritus caused by neuraxial morphine. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Medicina Universitaria is the property of Medicina Universitaria and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=109202194
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 107
    Subjects:
      – SubjectFull: ONDANSETRON
        Type: general
      – SubjectFull: NALBUPHINE
        Type: general
      – SubjectFull: ITCHING
        Type: general
      – SubjectFull: MORPHINE
        Type: general
      – SubjectFull: ANALGESIA
        Type: general
      – SubjectFull: PHYSIOLOGY
        Type: general
      – SubjectFull: THERAPEUTICS
        Type: general
    Titles:
      – TitleFull: Comparison of the efficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cruz-Ferretti, U.
      – PersonEntity:
          Name:
            NameFull: Llanes-Garza, H. A.
      – PersonEntity:
          Name:
            NameFull: López-Cabrera, N. G.
      – PersonEntity:
          Name:
            NameFull: Espinosa-Galindo, A. M.
      – PersonEntity:
          Name:
            NameFull: Palacios-Ríos, D.
      – PersonEntity:
          Name:
            NameFull: Cano-García, M. A.
      – PersonEntity:
          Name:
            NameFull: Estrada-Solís, Y. N.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: jul-sep2014
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 16655796
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 64
          Titles:
            – TitleFull: Medicina Universitaria
              Type: main
ResultId 1